Age at surgery (years): | |
Mean | 39 |
Median | 38 |
Range | 23–67 |
Stage (FIGO 2009), N (%) | |
IA2 | 33 (33%) |
IB1 | 67 (67%) |
Histology, N (%) | |
Squamous cell carcinoma | 48 (48%) |
Adenocarcinoma | 52 (52%) |
Surgical approach, N (%) | |
Laparoscopic | 83 (83%) |
Robotic | 13 (13%) |
Open | 4 (4%) |
Lymph node assessment, N (%) | |
Full lymph node dissection | 58 (58%) |
Sentinel lymph node biopsy+full lymph node dissection | 38 (38%) |
Sentinel lymph node biopsy alone | 4 (4%) |